Australian Statistics on Medicines 2010

MUSCULO-SKELETAL SYSTEM
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
ANTIINFLAMMATORY/ANTIRHEUMATIC PRODDUCTS,NON-STEROIDS
ACETIC ACID DERIVATIVES AND RELATED SUBSTANCES

M01AB05

DICLOFENAC

P

1299J

Tablet 25mg (enteric coated)

0.10

GM

79,100

1,010,483

P

1300K

Tablet 50mg (enteric coated) 50

0.10

GM

906,895

10,001,304

P

1302M

Suppository 100mg 40

0.10

GM

14,719

354,508

A

16918

Tablet 25mg 20

0.10

GM

11,212

—

A

16971

Tablet 25mg 10

0.10

GM

3,042

—

A

17454

Tablet 25mg 30

0.10

GM

12,426

—

A

18567

Tablet 50mg 20

0.10

GM

139,904

—

A

18726

Suppository 50mg 10

0.10

GM

600

—

A

20662

Tablet 25mg (enteric coated) 30

0.10

GM

2,738

—

A

20718

Tablet 25mg 30

0.10

GM

556

—

A

21270

Tablet 50mg (enteric coated) 50

0.10

GM

1,412

—

P

5076E

Tablet 25mg (enteric coated)

0.10

GM

215

2,108

P

5077F

Tablet 50mg (enteric coated)

0.10

GM

1,453

14,622

P

5362F

Tablet 50mg (enteric coated) 50

0.10

GM

1,381

22,177

P

5365J

Tablet 50mg (enteric coated) 50

0.10

GM

640

761

M01AB55

DICLOFENAC with MISOPROSTOL

P

4190M

Tablet 50mg 200ug 60

—

—

1,414

54,801

M01AB01

INDOMETHACIN

P

2454E

Capsule 25mg

0.10

GM

296,550

3,521,904

P

2757D

Suppository 100mg

0.10

GM

53,991

1,176,314

P

5377B

Capsule 25mg 100

0.10

GM

205

3,318

P

5378C

Suppository 100mg 40

0.10

GM

161

4,110

P

5379D

Capsule 25mg 100

0.10

GM

211

—

M01AB15

KETOROLAC

A

13986

Ampoule 30mg per 1mL 5

30.00

MG

1,020

—

A

14188

Tablet 10mg 30

30.00

MG

1,204

—

A

14950

Ampoule 10mg per 1mL

30.00

MG

242

—

M01AB02

SULINDAC

P

2047R

Tablet 100mg

0.40

GM

3,189

51,425

P

2048T

Tablet 200mg

0.40

GM

9,985

152,763

OXICAMS

M01AC06

MELOXICAM

P

8561N

Tablet 7.5mg

15.00

MG

314,172

6,467,489

P

8562P

Tablet 15mg

15.00

MG

885,908

23,952,592

P

8887R

Capsule 7.5mg 30

15.00

MG

391,396

8,052,500

P

8888T

Capsule 15mg 30

15.00

MG

820,085

22,126,663

M01AC01

PIROXICAM

P

1895R

Dispersible tablet 10mg 50

20.00

MG

3,655

45,367

P

1896T

Dispersible tablet 20mg 25

20.00

MG

57,759

703,640

P

1897W

Capsule 10mg

20.00

MG

26,649

332,459

P

1898X

Capsule 20mg

20.00

MG

124,038

1,509,730

MUSCULO-SKELETAL SYSTEM
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
ANTIINFLAMMATORY/ANTIRHEUMATIC PRODDUCTS,NON-STEROIDS

P

5203W

Capsule 10mg

20.00

MG

222

2,658

PROPIONIC ACID DERIVATIVES

M01AE01

IBUPROFEN

A

13267

Tablet 200mg 12

1.20

GM

116

—

A

13268

Tablet 200mg 24

1.20

GM

3,126

—

A

13372

Tablet 200mg 48

1.20

GM

2,244

—

A

15401

Susp 0.1/5mL 100mL

1.20

GM

427

—

A

21048

Tablet 200mg 50

1.20

GM

3,048

—

P

3190X

Tablet 400mg

1.20

GM

200,186

2,891,395

P

3192B

Tablet 400mg 30

1.20

GM

219,043

2,013,771

P

3198H

Tablet 200mg

1.20

GM

3,368

38,859

P

5123P

Tablet 400mg

1.20

GM

407

4,526

P

5124Q

Tablet 400mg 30

1.20

GM

7,867

71,185

P

5368M

Tablet 400mg 100

1.20

GM

719

12,230

M01AE51

IBUPROFEN with CODEINE

A

17716

Tablet 200mg/12.8mg 48

—

—

6,840

—

A

18882

Tablet 200mg/12.8mg 48

—

—

3,226

—

A

18887

Tablet 200mg/12.8mg 48

—

—

3,621

—

A

19136

Tablet 200mg/12.5mg 12

—

—

6,375

—

A

19137

Tablet 200mg/12.5mg 12

—

—

24,315

—

A

19138

Tablet 200mg/12.5mg 12

—

—

9,179

—

A

19795

Tablet 200mg/12.8mg 75

—

—

3,593

—

A

20613

Tablet 200mg/12.8mg 48

—

—

1,370

—

A

21001

Tablet 200mg/12.5mg 15

—

—

1,955

—

A

21002

Tablet 200mg/12.5mg 30

—

—

24,307

—

A

21099

Tablet 200mg/12.8mg 30

—

—

32,522

—

A

21114

Tablet 200mg/12.8mg 30

—

—

12,567

—

A

21115

Tablet 200mg/12.8mg 24

—

—

2,503

—

A

21127

Tablet 200mg/12.8mg 24

—

—

208

—

A

21132

Tablet 200mg/12.8mg 24

—

—

156

—

A

21135

Tablet 200mg/12.8mg 24

—

—

330

—

A

21165

Tablet 200mg/12.8mg 24

—

—

116

—

M01AE03

KETOPROFEN

P

1588N

Suppository 100mg

0.15

GM

1,929

48,732

P

1590Q

Capsules 200mg (sustained release) 28

0.15

GM

144,168

2,816,866

P

5136H

Capsule 200mg (sustained release)

0.15

GM

214

3,687

M01AE02

NAPROXEN

A

11401

Tablet 275mg 12

0.50

GM

276

—

P

1614Y

Tablet 750mg (sustained release) 28

0.50

GM

94,409

1,166,139

P

1615B

Tablet 1g (sustained release) 28

0.50

GM

225,070

3,225,580

P

1658G

Oral suspension 125mg per 5mL 474mL

0.50

GM

828

66,919

P

1659H

Tablet 500mg

0.50

GM

168,994

2,175,379

P

1674D

Tablet 250mg

0.50

GM

43,173

565,129

MUSCULO-SKELETAL SYSTEM
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
ANTIINFLAMMATORY/ANTIRHEUMATIC PRODDUCTS,NON-STEROIDS

P

1795L

Tablet 550mg 50

0.50

GM

40,227

525,249

P

5177L

Tablet 500mg

0.50

GM

173

2,085

P

5179N

Tablet 1g (sustained release)

0.50

GM

115

1,523

P

5346J

Tablet 500mg 50

0.50

GM

238

3,062

P

5348L

Tablet 1g (sustained release) 28

0.50

GM

370

5,779

M01AE11

TIAPROFENIC ACID

P

2103Q

Tablet 300mg

600.00

MG

9,151

160,809

FENAMATES

M01AG01

MEFENAMIC ACID

A

11611

Capsule 250mg 20

1.00

GM

358

—

P

1824B

Capsule 250mg

1.00

GM

47,423

859,046

COXIBS

M01AH01

CELECOXIB

A

17093

Capsule 200mg 10

0.20

GM

1,973

—

P

8439E

Capsule 100mg 60

0.20

GM

233,556

7,506,837

P

8440F

Capsule 200mg 60

0.20

GM

1,287,206

42,556,625

M01AH05

ETORICOXIB

A

20525

Tablet 30mg 30

60.00

MG

2,054

—

A

20526

Tablet 60mg 30

60.00

MG

5,531

—

A

20527

Tablet 120mg 10

60.00

MG

3,374

—

OTHER ANTIINFL./ANTIRHEUMATIC AGENTS, NON-STEROIDS

M01AX12

PENTOSAN-POLY SULFATE SODIUM

A

14955

Capsule 100mg 100

—

—

154

—

SPECIFIC ANTIRHEUMATIC AGENTS

GOLD PREPARATIONS

M01CB03

AURANOFIN

P

1095P

Tablet 3mg

6.00

MG

2,713

175,500

M01CB01

SODIUM AUROTHIOMALATE

P

2016D

Injection 10mg

2.40

MG

118

7,731

P

2017E

Injection 20mg

2.40

MG

241

23,522

P

2018F

Injection 50mg

2.40

MG

1,408

193,696

PENICILLAMINE

M01CC01

PENICILLAMINE

P

2721F

Tablet 125mg

0.50

GM

414

15,630

P

2838J

Tablet 250mg

0.50

GM

3,838

195,840

MUSCULO-SKELETAL SYSTEM
TOPICAL PRODUCTS FOR JOINT and MUSCULAR PAIN
TOPICAL PRODUCTS FOR JOINT and MUSCULAR PAIN
ANTIINFL. PREP., NON-STEROIDS FOR TOPICAL USE

M02AA15

DICLOFENAC

A

14860

Gel 50g 1

—

—

2,919

—

A

14861

Gel 100g 1

—

—

12,377

—

A

14979

Gel 20g 1

—

—

704

—

M02AA10

KETOPROFEN

A

14949

Gel 2.5% 60g 1

—

—

230

—

M02AA07

PIROXICAM

A

15090

Gel 0.5% 25g 1

—

—

170

—

A

15091

Gel 0.5% 50g 1

—

—

896

—

CAPSAICIN and SIMILAR AGENTS

M02AB

CAPSAICIN

A

15579

Cream 0.025% 45g

—

—

303

—

PREPARATIONS with SALICYLIC ACID DERIVATIVES

M02AC

METHYL SALICYLATE

A

12931

Cream 100g 1

—

—

1,597

—

P

4022Q

Compound Cream APF 100gm

—

—

2,429

34,666

P

4023R

Ointment BP 100gm

—

—

994

12,467

P

4026X

Liniment APF 100gm

—

—

1,297

12,887

M02AC

METHYL SALICYLATE with MENTHOL with EUCALYPTUS OIL

A

11224

Cream 125g 1

—

—

921

—

MUSCULO-SKELETAL SYSTEM
MUSCLE RELAXANTS
MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS
ETHERS, CHEMICALLY CLOSE TO ANTIHISTAMINES

M03BC01

ORPHENADRINE CITRATE

A

11353

Tablet 100mg 100

0.12

GM

7,047

—

M03BC51

ORPHENADRINE CITRATE with PARACETAMOL

A

11354

Tablet 35mg-450mg 100

0.12

GM

4,682

—

A

21041

Tablet 35mg-450mg 24

0.12

GM

5,791

—

OTHER CENTRALLY ACTING AGENTS

M03BX01

BACLOFEN

P

2729P

Tablet 10mg

50.00

MG

103,082

3,552,683

P

2730Q

Tablet 25mg

50.00

MG

52,016

3,307,782

P

6284R

Intrathecal injection 10mg in 5mL 10

0.55

MG

133

87,907

MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS

DANTROLENE AND DERIVATIVES

M03CA01

DANTROLENE SODIUM

P

1779P

Capsule 25mg

0.10

GM

5,456

366,583

P

1780Q

Capsule 50mg

0.10

GM

2,477

187,357

MUSCULO-SKELETAL SYSTEM
ANTIGOUT PREPARATIONS
ANTIGOUT PREPARATIONS
PREPARATIONS INHIBITING URIC ACID PRODUCTION

M04AA01

ALLOPURINOL

P

2600W

Tablet 100mg

0.40

GM

287,890

3,757,692

P

2604C

Tablet 300mg

0.40

GM

826,110

8,577,193

PREPARATIONS INCREASING URIC ACID EXCRETION

M04AB01

PROBENECID

P

1940D

Tablet 500mg

1.00

GM

18,677

1,400,192

PREPARATIONS WITH NO EFFECT ON URIC ACID METABOLISM

M04AC01

COLCHICINE

P

1227N

Tablet 500ug

1.00

MG

201,093

2,242,576

P

3410L

Tablet 500ug 30

1.00

MG

37,975

430,126

MUSCULO-SKELETAL SYSTEM
DRUGS FOR TREATMENT OF BONE DISEASES
DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
BISPHOSPHONATES

M05BA04

ALENDRONIC ACID

P

8090T

Tablet 40mg

10.00

MG

12,198

1,643,044

P

8511Y

Tablet 70mg alendronic acid 4

10.00

MG

711,273

32,863,889

M05BA02

CLODRONIC ACID

P

8132B

Capsule equivalent to 400mg sodium clodronate

1.60

GM

666

226,692

P

8265B

Capsule equivalent to 800mg sodium clodronate

1.60

GM

12,350

4,831,032

M05BA01

DISODIUM ETIDRONATE

P

2920Q

Tablet 200mg

0.40

GM

498

66,273

M05BA03

DISODIUM PAMIDRONATE

P

6223M

Vial pdr for IV infuse 90mg amp solvent 10mL

60.00

MG

2,678

1,189,002

P

6289B

Concentrated injection 90mg in 10mL

60.00

MG

440

178,360

P

8209C

2 Vials pdr for IV infuse 30mg 2 amp solvent 10mL

60.00

MG

416

113,788

P

8462J

Concentrated injection 30mg in 10mL

60.00

MG

189

42,616

P

8463K

Concentrated injection 60mg in 10mL

60.00

MG

183

50,268

M05BA06

IBANDRONIC ACID

P

9357L

Tablet 50mg (as ibandronate sodium monohydrate) 28

5.00

MG

5,449

1,860,022

P

9619G

Inj for I.V. infusion equiv 6mg (as ibandronate sodium monohydrate) in 6mL

6.00

MG

1,303

492,601

M05BA07

RISEDRONIC ACID

P

4444X

Tablet 35mg 4

5.00

MG

2,823

150,553

P

8481J

Tablet 5mg 28

5.00

MG

9,311

495,642

P

8482K

Tablet 30mg 28

5.00

MG

3,173

965,271

P

8621R

Tablet 35mg

5.00

MG

346,829

18,458,744

P

9391G

Tablet 150mg 1

5.00

MG

247,184

14,069,540

M05BA05

TILUDRONIC ACID

P

8267D

Tablet 200mg

0.40

MG

503

153,153

M05BA08

ZOLEDRONIC ACID

P

6371H

Injection concentrate I.V. infusion 4mg (as monohydrate) in 5mL

4.00

MG

21,001

10,463,262

P

9288W

Solution for I.V. infusion 5mg (as monohydrate) in 100mL

4.00

MG

22,261

12,994,751

P

9350D

Solution for I.V. infusion 5mg (as monohydrate) in 100mL

4.00

MG

529

311,296

BISPHOSPHONATES, COMBINATIONS

M05BB05

ALENDRONATE SODIUM with COLECALCIFEROL and CALCIUM CARBONATE

P

9351E

Pack 4 tablets equiv 70mg alendronic acid with 140ug colecalciferol, 48 tablets calcium carbonate 1.25g

10.00

MG

47,351

2,169,327

M05BB03

ALENDRONIC ACID and COLECALCIFEROL

P

9012H

Tablet equiv to 70mg alendronic with 70ug Colecal

—

—

436,820

20,196,881

P

9183H

Tablet equiv to 70mg alendronic with 140ug Colecal

—

—

500,936

23,136,793

M05BB01

ETIDRONIC ACID AND CALCIUM

P

8056B

28 tabs 200mg and 76 tabs calcium (equiv 500mg)

—

—

7,644

539,815

M05BB04

RISEDRONIC ACID and CALCIUM CARBONATE with COLECALCIFEROL

P

4380M

4 tablets 35mg and 24 sachets granules 2.5g-22ug

—

—

1,768

94,193

P

9147K

4 tablets 35mg and 24 sachets granules 2.5g-22ug

—

—

325,827

17,360,601

M05BB02

RISEDRONIC SODIUM with CALCIUM CARBONATE

P

4059P

Pack containing 4 tablets 35mg and 24 tabs 1.25g

—

—

3,097

165,544

MUSCULO-SKELETAL SYSTEM
DRUGS FOR TREATMENT OF BONE DISEASES
DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION

P

8899J

Pack containing 4 tablets 35mg and 24 tabs 1.25g

—

—

467,015

24,887,189

OTHER DRUGS AFFECTING BONE STRUCTURE

M05BX04

DENOSUMAB

P

5457F

Injection 60mg in 1 ml prefilled syringe

0.33

MG

155

47,253

M05BX03

STRONTIUM RANELATE

P

3036T

Granules for oral suspension 2g, 28 Sachets

2.00

GM

298,009

15,869,745